Kevin E. Lofton - 03 May 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Director
Signature
/s/ Edward S. Son by Power of Attorney for Kevin E. Lofton
Issuer symbol
GILD
Transactions as of
03 May 2023
Transactions value $
$808,245
Form type
4
Filing time
04 May 2023, 17:57:05 UTC
Previous filing
03 May 2023
Next filing
30 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Award $0 +1.89K +2.08% $0.00 92.7K 03 May 2023 By Trust F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Non-qualified Stock Option (Right to Buy) Award $808K +10.2K $79.45 10.2K 03 May 2023 Common Stock 10.2K $79.45 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 1,887 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 3, 2023.
F2 Shares are held in a Revocable Living Trust.
F3 100% of the shares subject to the stock option vested immediately upon the grant date of May 3, 2023.